Table 1.
|
||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BLM | 6′-deoxy-BLM Z | BLM Z | ZBM | |||||||||||||||||
| ||||||||||||||||||||
Base | % Cleavage | Sequence | Base | % Cleavage | Sequence | Base | % Cleavage | Sequence | Base | % Cleavage | Sequence | |||||||||
1 | 188 | 2.59 | CT | GT | AT | 188 | 2.96 | CT | GT | AT | 188 | 2.48 | CT | GT | AT | 89 | 3.73 | GT | GT | AC |
2 | 179 | 2.55 | CT | GT | AA | 179 | 2.55 | CT | GT | AA | 179 | 2.43 | CT | GT | AA | 80 | 3.32 | GT | GT | AT |
3 | 325 | 2.49 | TC | GT | AT | 116 | 2.52 | AT | GT | AT | 386 | 2.41 | TT | GT | AT | 69 | 3.18 | TT | GT | GT |
4 | 143 | 2.48 | TT | GT | AA | 152 | 2.50 | TT | GT | AT | 152 | 2.38 | TT | GT | AT | 497 | 3.04 | GC | GT | AA |
5 | 152 | 2.48 | TT | GT | AT | 317 | 2.48 | TT | GT | AT | 325 | 2.34 | TC | GT | AT | 78 | 3.00 | TT | GT | GT |
6 | 386 | 2.45 | TT | GT | AT | 197 | 2.44 | CT | GT | AC | 143 | 2.32 | TT | GT | AA | 87 | 2.99 | TT | GT | GT |
7 | 261 | 2.43 | TC | GT | AA | 107 | 2.40 | AT | GT | AA | 197 | 2.30 | CT | GT | AC | 62 | 2.70 | GT | GT | AG |
8 | 107 | 2.42 | AT | GT | AA | 261 | 2.37 | TC | GT | AA | 317 | 2.30 | TT | GT | AT | 60 | 2.57 | TT | GT | GT |
9 | 116 | 2.41 | AT | GT | AT | 422 | 2.36 | TT | GC | CT | 261 | 2.30 | TC | GT | AA | 125 | 2.50 | AT | GT | AC |
10 | 317 | 2.37 | TT | GT | AT | 386 | 2.34 | TT | GT | AT | 116 | 2.25 | AT | GT | AT | 197 | 2.49 | CT | GT | AC |
11 | 253 | 2.28 | TT | GT | AA | 143 | 2.33 | TT | GT | AA | 253 | 2.14 | TT | GT | AA | 116 | 2.48 | AT | GT | AT |
12 | 49 | 2.22 | GG | GT | AA | 325 | 2.30 | TC | GT | AT | 107 | 2.14 | AT | GT | AA | 71 | 2.38 | GT | GT | AA |
13 | 170 | 2.15 | CT | GT | AG | 170 | 2.23 | CT | GT | AG | 134 | 2.04 | TT | GT | AG | 98 | 2.29 | AT | GT | AG |
14 | 134 | 2.11 | TT | GT | AG | 253 | 2.17 | TT | GT | AA | 422 | 2.02 | TT | GC | CT | 293 | 2.21 | TC | GT | AC |
15 | 197 | 2.07 | CT | GT | AC | 221 | 2.15 | TT | GT | AG | 161 | 2.00 | TT | GT | AC | 161 | 2.19 | TT | GT | AC |
16 | 161 | 2.07 | TT | GT | AC | 161 | 2.14 | TT | GT | AC | 170 | 2.00 | CT | GT | AG | 325 | 2.06 | TC | GT | AT |
17 | 221 | 2.06 | TT | GT | AG | 285 | 2.07 | TT | GT | AC | 221 | 1.91 | TT | GT | AG | 188 | 2.06 | CT | GT | AT |
18 | 497 | 2.05 | GC | GT | AA | 134 | 2.00 | TT | GT | AG | 285 | 1.89 | TT | GT | AC | 386 | 2.03 | TT | GT | AT |
19 | 229 | 1.99 | TC | GT | AG | 125 | 1.88 | AT | GT | AC | 452 | 1.84 | GG | GT | TA | 382 | 2.00 | GT | GT | TT |
20 | 293 | 1.90 | TC | GT | AC | 293 | 1.87 | TC | GT | AC | 293 | 1.83 | TC | GT | AC | 285 | 1.92 | TT | GT | AC |
The 20 most highly cleaved sites for each compound were sorted based on their relative cleavage intensity in decreasing order. The values of the cleavage intensity (percentage cleavage) has been normalised to allow for profile comparison between the analogues. In addition, the sequence of the cleavage sites are shown - the primary site in bold and their flanking nucleotides in plain text.